# Boehringer Ingelheim Pharmaceuticals, Inc. – FDA Inspection, Sep 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/9c62d459-d5fc-4614-8d41-987968509962
Source feed: FDA_Inspections

> FDA inspection 1281125 of Boehringer Ingelheim Pharmaceuticals, Inc., September 11, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 19 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281125
- Company Name: Boehringer Ingelheim Pharmaceuticals, Inc.
- Inspection Date: 2025-09-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1334848 - 2026-08-25
- FDA Inspection 1235545 - 2024-05-02
- FDA Inspection 1219707 - 2023-09-22
- [FDA Inspection 1112627 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/3cec078a-63a0-4054-aba3-a7b39a8fad4e)
- [FDA Inspection 1073537 - 2018-12-06](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/e71d8ac5-5980-4791-92de-944874b88e24)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
